STEFANIE GOODRICH: Open Payments
NPI 1689665135 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,441 in 117 payments from 17 companies in 2025. Trend: 2023 $2,780 · 2024 $3,303 · 2025 $2,441
Food & beverage: $2,346Education: $95
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $376 |
| Janssen Biotech, Inc. | 8 | $314 |
| ABBVIE INC. | 26 | $266 |
| Galderma Laboratories, L.P. | 19 | $238 |
| LEO Pharma Inc. | 10 | $209 |
| Incyte Corporation | 10 | $199 |
| Regeneron Healthcare Solutions, Inc. | 7 | $157 |
| Amgen Inc. | 5 | $136 |
| GENZYME CORPORATION | 3 | $121 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
Products named: Bimzelx, TREMFYA, DUPIXENT, OPZELURA, SKYRIZI, NEMLUVIO, Otezla, Sotyktu.
Industry payments across MA — which companies pay providers there.
